Demographic and temporal variations in gallbladder adenocarcinoma and neuroendocrine carcinoma: insights from a retrospective analysis of the national cancer database

被引:0
|
作者
Louis, Mena [1 ]
Ghosh, Aditya K. [2 ]
Silin, Nawras [2 ]
Dakkak, Tahani [3 ]
Rynarzewska, Ania Izabela [4 ]
Cawthon, Mariah [1 ]
Grabill, Nathaniel [1 ]
Robinson, Shane [3 ]
Jones, Louise [3 ]
Royall, Nelson A. [5 ]
机构
[1] Northeast Georgia Med Ctr, Gen Surg, Gainesville, GA USA
[2] Northeast Georgia Med Ctr, Internal Med, Gainesville, GA USA
[3] Northeast Georgia Med Ctr, GME Res & Qual Improvement, Gainesville, GA USA
[4] Georgia Coll & State Univ, Milledgeville, GA USA
[5] Northeast Georgia Med Ctr, Gen Surg Residency Program, Hepato pancreato Biliary Surg, Gainesville, GA 30501 USA
关键词
Gallbladder cancer; NCDB; Observational; Adenocarcinoma; Neuroendocrine carcinoma; Demographic variables; Epidemiology; Targeted screening; EPIDEMIOLOGY;
D O I
10.1007/s10552-025-01967-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Gallbladder adenocarcinoma is the most common histologic subtype of gallbladder malignancies. In contrast, gallbladder neuroendocrine carcinomas are rare and poorly studied. This study aims to identify the demographic variables that may be associated with each histologic subtype. Methods A retrospective analysis was conducted on 53,447 patients diagnosed with gallbladder neoplasms using data from the National Cancer Database (NCDB) between 2011 and 2020. Associations between demographic variables and the incidence of gallbladder adenocarcinoma and neuroendocrine carcinoma were compared using chi-square tests and post hoc analyses. Results A total of 51,694 (96.7%) patients had adenocarcinoma, and 1753 (3.3%) had neuroendocrine histologic subtypes. The comparative analysis revealed significant associations with age, gender, and race (p < 0.05). Neuroendocrine carcinoma patients were diagnosed at a younger age compared to those with adenocarcinoma (z = 14.7). Moreover, patients with privately managed insurance had a higher likelihood of neuroendocrine carcinoma (z = 5.7), while those with Medicare were less likely (z = - 4.7). Gender differences were also notable; males were more predisposed to neuroendocrine carcinoma (z = 4.4, OR = 1.3), while females were less so (z = - 3.1). A significant increase in neuroendocrine cases was observed after 2016 (z = 2.4), while the incidence of adenocarcinoma subtypes was stable. Notable racial disparities in the diagnosis of gallbladder cancer were identified with black patients more likely to have neuroendocrine carcinoma. Conclusion This study highlights the differences in demographic and clinical characteristics of patients diagnosed with gallbladder neuroendocrine carcinomas compared to adenocarcinoma tumors. These findings highlight potential opportunities for targeted screening programs to enhance early detection efforts.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] DIFFERENCES IN GALLBLADDER NEUROENDOCRINE AND ADENOCARCINOMA HISTOLOGIC SUBTYPES IN THE UNITED STATES: A RETROSPECTIVE STUDY OF THE NATIONAL CANCER DATABASE
    Louis, Mena
    Ghosh, Aditya
    Royall, Nelson A.
    Robinson, Shane
    Rynarzewska, Ania I.
    GASTROENTEROLOGY, 2024, 166 (05) : S1890 - S1891
  • [2] Demographic and socioeconomic analysis of patients with glucagonoma: Insights from the National Cancer Database
    Diagne, Yaye Fatou
    Alban, Sierra
    Reddy, Nisha
    Loomer, Michael
    Silberstein, Peter T.
    Heise, Craig
    Hsia, Beau
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Gallbladder squamous cell carcinoma: An analysis of 1084 cases from the National Cancer Database
    Ayabe, Reed I.
    Wach, Michael M.
    Ruff, Samantha M.
    Diggs, Laurence P.
    Martin, Sean P.
    Wiemken, Timothy
    Hinyard, Leslie
    Davis, Jeremy L.
    Luu, Carrie
    Hernandez, Jonathan M.
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (04) : 716 - 722
  • [4] Gallbladder Neuroendocrine Carcinoma. Is It Different from Adenocarcinoma?
    Raja, K.
    Pottakkat, B.
    Chandrasekar, S.
    NEUROENDOCRINOLOGY, 2017, 105 : 280 - 280
  • [5] Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database
    Murimwa, Gilbert
    Hester, Caitlin
    Mansour, John C.
    Polanco, Patricio M.
    Porembka, Matthew R.
    Wang, Sam C.
    Zeh, Herbert J., Jr.
    Yopp, Adam C.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (07) : 1815 - 1827
  • [6] Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database
    Gilbert Murimwa
    Caitlin Hester
    John C. Mansour
    Patricio M. Polanco
    Matthew R. Porembka
    Sam C. Wang
    Herbert J. Zeh
    Adam C. Yopp
    Journal of Gastrointestinal Surgery, 2021, 25 : 1815 - 1827
  • [7] Ceruminous adenocarcinoma: A National Cancer Database study of demographic characteristics
    Hsia, Beau
    Keirns, Darby
    Silberstein, Peter T.
    Wu, Xinxin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Primary Gallbladder Neuroendocrine Tumors: Insights into a Rare Histology Using a Large National Database
    Reed I. Ayabe
    Michael Wach
    Samantha Ruff
    Sean Martin
    Laurence Diggs
    Timothy Wiemken
    Leslie Hinyard
    Jeremy L. Davis
    Carrie Luu
    Jonathan M. Hernandez
    Annals of Surgical Oncology, 2019, 26 : 3577 - 3585
  • [9] Primary Gallbladder Neuroendocrine Tumors: Insights into a Rare Histology Using a Large National Database
    Ayabe, Reed, I
    Wach, Michael
    Ruff, Samantha
    Martin, Sean
    Diggs, Laurence
    Wiemken, Timothy
    Hinyard, Leslie
    Davis, Jeremy L.
    Luu, Carrie
    Hernandez, Jonathan M.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (11) : 3577 - 3585
  • [10] Urachal Carcinoma: Insights From a National Database
    Orsini, Angelo
    Bignante, Gabriele
    Lasorsa, Francesco
    Bologna, Eugenio
    Mossack, Spencer M.
    Pacini, Matteo
    Marchioni, Michele
    Porpiglia, Francesco
    Lucarelli, Giuseppe
    Schips, Luigi
    Steinberg, Gary D.
    Cherullo, Edward E.
    Autorino, Riccardo
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)